Literature DB >> 35431559

Aero-Allergen Sensitization in the General Population: Longitudinal Analyses of the LEAD (Lung Heart Social Body) Study.

Franziska Kölli1,2, Marie-Kathrin Breyer2,3, Sylvia Hartl1,2,3, Otto Burghuber1,2, Emiel F M Wouters2,4, Torben Sigsgaard5, Wolfgang Pohl6, Gabriele Kohlböck2, Robab Breyer-Kohansal2,3.   

Abstract

Background: Monitoring of sensitization may become a non-invasive marker of impaired epithelial barrier function related to changing environmental conditions. Objective: To longitudinally evaluate the prevalence and associated factors for positive skin prick tests (SPT) in a general population cohort.
Methods: Baseline and 4-year follow-up data from the longitudinal LEAD study are used for the current analyses. Risk factors for SPT were analyzed by multivariate binary logistic regression analyses, including residence (urban/rural), sex, socioeconomic status (SES), allergic and/or respiratory diseases, lung function testing, blood eosinophils, body composition, lifestyle habits, family history, pets in household, and exposure to tobacco smoke in childhood/adolescence (6-18 years) and adulthood (≥19 years).
Results: In total, 1439 children/adolescents and 9844 adults with valid SPTs were included in these analyses. The prevalence of sensitization at baseline was 37.6% and was higher in males in every age group, except 10-<15 years. Individuals with doctor´s diagnosed allergy, asthma or parental allergy were more likely to have a positive SPT; in adulthood, sensitization was more common in those with a high SES. A lower occurrence of sensitization was associated with the presence of a dog in the household in childhood/adolescence and with smoking in adulthood. The prevalence and intensity (number of positive SPT reactions) increased after a 4-year follow-up, especially in children/adolescents.
Conclusion: Sensitization is common in the general Austrian population and more likely in males than females. Longitudinal monitoring of sensitization in children/adolescents may identify environmental triggers related to changes in urbanization, industrialization and domestic lifestyle. ClinicalTrials.gov NCT01727518.
© 2022 Kölli et al.

Entities:  

Keywords:  adults; aero-allergens; allergy; childhood/adolescence; sensitization

Year:  2022        PMID: 35431559      PMCID: PMC9012316          DOI: 10.2147/JAA.S349614

Source DB:  PubMed          Journal:  J Asthma Allergy        ISSN: 1178-6965


Introduction

Over the last half century, allergy to environmental antigens has become more common, with prevalence varying from 17–69%,1,2 and house dust mite3 and grass pollen4 being the most common aero-allergens.5 Epidemiological studies suggest a higher prevalence of sensitization in males,2,6–8 younger individuals,4,5,9 and in those with higher educational status,5 and lower prevalence in the elderly,4,10 with mixed data on the correlation with smoking.11,12 Sensitization is a well-known risk factor for the development of respiratory symptoms and disease manifestations such as allergic rhinitis, allergic conjunctivitis, wheezing, impaired lung function, and asthma.4,13–15 Early-life sensitization is related to decreased lung function by school age,14 and in adolescence,16 and to wheezing,17 eczema,17 and a higher risk of developing asthma by 7 years of age.14 Family history of allergy is not only known to be a risk factor for sensitization and allergy in offspring18 but also associated with allergic symptoms in offspring, especially eczema.13 It is also known that there are differences in dog dander sensitization and it is possible to be sensitized only to male or female dogs.19 The skin prick test (SPT) is a minimally invasive, inexpensive and reliable diagnostic method of detecting an immediate (Type I) sensitization and is therefore suitable to assess the presence of allergy. Longitudinal data on the progression of SPT reactivity from childhood to adulthood are scarce. One such study followed a cohort of 200 Healthy newborns in Finland from birth to 20 years of age; SPT positivity at a young age forecasted SPT positivity in adulthood, with an increase in sensitization over 6- and 15-year follow-up periods.20 In contrast, in a Swedish population study in adults the prevalence of positive SPTs decreased with increasing age.10 However, longitudinal data from childhood up to the elderly population are still missing and analyzed in this work. The Austrian LEAD (Lung, hEart, sociAl, boDy) study, a population-based longitudinal cohort offers the opportunity to assess allergy prevalence in different age groups, as well as to evaluate SPT positivity longitudinally over the whole life span.21 The current analyses aim to investigate the prevalence and age- and sex distribution of positive SPT in the general population both at baseline and after a 4-year follow-up. Furthermore, determining factors associated with positive SPT at baseline are studied.

Methods

Ethics

The Austrian LEAD study is approved by the local Ethics committee of Vienna (protocol number: EK-11-117-0711). All participants signed written informed consent; those for children under the age of 18 had to be signed by their parents or legal representative.21 The manuscript was conducted in accordance with the Declaration of Helsinki. Data is accessible from one of the co-authors Priv.-Doz. Dr. Breyer-Kohansal.

Study Design

The Austrian LEAD study (ClinicalTrials.gov; NCT01727518) has been described in detail elsewhere.21 It is a longitudinal, observational, population-based cohort study that has recruited 11,423 participants (47.6% male) aged 6–82 years. The cohort was randomly recruited in Vienna and Lower Austria, stratified by age, sex and residential area. Comparison with data published by the Governmental Statistic Department and the Austrian Governmental Microcensus showed almost identical distribution of age, gender, ethnicity, educational level and smoking status supporting the representativeness of the LEAD cohort for the Austrian population.21 The baseline visit took place between 2012 and 2016, with the 4-year-follow up taking place between 2017 and 2021. Exclusion criteria were limited to current pregnancy, current breastfeeding, or poor language skills.

Skin Prick Test

Antihistamines or glucocorticoids were withdrawn for at least 48 h before testing. At the baseline and follow-up visits, SPT was performed on the forearms of all participants by trained technicians.22 The SPT was positive if there was a reaction ≥3 mm diameter for at least one of the allergens. The following aero-allergens were tested: ash tree, tree pollen mix (hazel, alder, birch), grass mix (Anthoxantum, Dactylis, Lolium, Phleum and Poa), mugwort, ragweed, ribwort, mites mix (Dermatophagoides Farinae and Dermatophagoides Pteronyssinus), mildew, and dog and cat dander.21 In both phases, all allergens were obtained from the company “Alk-Abello” and were the identical allergens in both, in baseline and follow-up analyzes. Thus, a batch-to-batch consistency over 4 years was given. Positive (0.1% histamine) and negative (0.9% sodium chloride) controls were included in the test panel.

Individual Factors

The presence of allergy and/or asthma was based on doctor diagnosis, with self-reporting of respiratory and allergic symptoms (wheezing, cough, dyspnea, breathlessness, rhinoconjunctivitis and eczema). Information about diagnosed asthma in siblings or allergy in parents, smoking status and pack-years, second-hand smoking, parental smoking and pets in the household was collected by an interview-based questionnaire. A list of all factors is in the online supplement (). Lung function testing was performed according to international recommendations,23 after an adequate wash-out for any inhalation therapy. Low lung function was defined as forced expiratory volume in 1 second (FEV1) below the lower limit of normal (LLN) according to Global Lung Initiative (GLI) values.24 Airflow limitation was defined as FEV1/forced vital capacity (FVC) below the GLI LLN.25 Body composition was assessed by calculation of the body mass index (BMI), and measurement of the fat mass index (FMI) and fat-free mass index (FFMI) using whole-body dual energy X‐ray absorptiometry (DEXA; Lunar ProdigyTM, GE Healthcare©, Chicago, IL, USA). Socioeconomic status (SES) categories were based on occupational status, educational status, income status, and a combined score (for children the SES of their parents or parent with the major child custody was used).

Statistical Analysis

Statistical analyses were performed with IBM SPSS version 26.0, with level of significance set at <5%. All reported p-values are based on two-sided tests. Univariate inferential statistics for distribution comparisons include Χ2-tests for general crosstabs and Fisher’s exact tests for 2×2 tables. Statistically significant overall comparisons via Χ2-test in terms of body composition or smoking status were examined more closely using post-hoc tests for pairs of categories (Fisher´s exact tests). Indicators of risk were analyzed by binary logistic regression for childhood/adolescence and adulthood separately. Both forced entry model and backward regression model was calculated. Omnibus and Hosmer and Lemeshow goodness of fit tests were calculated for all regression models. All models were stratified by sex to consider the potential confounder. All analyses were performed separately for baseline childhood/adolescence (6–18 years) and adulthood (≥19 years) age categories. To compare SPT status between baseline and after 4-year follow-up, an alluvial plot in R was made for childhood/adolescence and adulthood categories.

Results

In total, 1439 children/adolescents aged 6–18 years and 9844 adults aged from 19–82 years with valid SPTs are included in these analyses (Table 1).
Table 1

Baseline Characteristics

Childhood/Adolescence N = 1439Adulthood N = 9844
Male N = 773 (53.7%)Female N = 666 (46.3%)Male N = 4587 (46.6%)Female N = 5257 (53.4%)
Age, years12.4 ± 3.712.6 ± 3.649.3 ± 16.349.3 ± 16.1
Height, cm153.9± 20.7150.9 ± 15.9177.5 ± 7.1164.1 ± 6.6
Weight, kg48.4 ± 19.945.2 ± 15.484.6 ± 14.168.1 ± 13.8
BMI, kg/m219.5 ± 4.119.2 ± 3.926.9 ± 4.325.3 ± 5.2
Fat mass index, kg/m24.3 ± 2.95.8 ±2.87.5 ± 3.29.7 ± 4.0
Fat free mass index, kg/m214.5 ± 2.412.7 ±1.418.3 ± 1.814.7 ± 1.6
FEV1, % predicted98.1 ± 11.997.2 ± 12.395.7 ± 14.998.6 ± 14.2
FVC, % predicted98.3 ± 11.398.1 ± 12.198.2 ± 13.0100.9 ± 12.8
FEV1/FVC, %86.0 ± 7.288.1 ± 9.777.2 ± 7.879.0 ± 7.3
Eosinophils, 109/L3.6 ± 3.12.8 ± 2.72.7 ± 1.92.3 ± 1.8
Smoking status
Never smoker731 (94.6)637 (95.6)1738 (37.9)2570 (48.9)
Former smoker1 (0.1)2 (0.3)1656 (36.1)1533 (29.2)
Current smoker41 (5.3)27 (4.1)1192 (26.0)1153 (21.9)
Second-hand smoking148 (19.2)143 (21.5)2736 (60.0)3275 (62.3)

Note: Data are mean ± standard deviation or number (%).

Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity.

Baseline Characteristics Note: Data are mean ± standard deviation or number (%). Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity.

Prevalence of Positive Skin Prick Test at Baseline

At baseline, the overall prevalence of a positive SPT for at least one allergen was 37.6% (N=4246), with 37.2% (N=535) in childhood/adolescence and 37.7% (N=3711) in adulthood. The prevalence was higher in males than females, both in childhood/adolescence (42.9% vs 30.5%; p<0.001) and adulthood (42.2% vs 33.7%; p<0.001) and was also higher in males in all age groups, with the exception of 10–<15 years (Figure 1). Peak prevalence was at 10–<15 years in females and 19–<29 years in males, then subsequently decreased steadily in both sexes (Figure 1).
Figure 1

Prevalence of positive skin prick test by age and gender at baseline. *p<0.05 male vs female.

Prevalence of positive skin prick test by age and gender at baseline. *p<0.05 male vs female. The overall mean number of positive SPT reactions per individual was 3.02 in childhood/adolescence and 3.37 in adulthood. Among the children/adolescents who were SPT positive, 11.3% had a reaction to ≥4 allergens compared to 14.9% in adults. We did not observe any association between the numbers of positive SPT reactions and family history of atopy. However, a higher number of positive SPT reactions was significantly associated with the presence of doctor´s diagnosed asthma, neuro-dermatitis or asthma, and allergic (rhinoconjunctivitis, eczema and breathlessness) and non-allergic symptoms (wheezing and sputum production), in both age groups ( and ). In the subgroup with at least one SPT, adults were more likely than children/adolescents to have rhino-conjunctivitis, eczema, doctor’s diagnosed asthma, high income or SES status, COPD/chronic bronchitis/emphysema, coughing or sputum production, airflow limitation, or a second-hand or paternal smoking history (). Furthermore, compared with adults with a positive SPT, children/adolescents were significantly more likely to be male, have an urban residence, to be diagnosed with neuro-dermatitis, to have a parent with an allergy, to demonstrate lung function reversibility, to have a history of maternal smoking (both ever and during pregnancy), and to currently have a pet in their household (). At baseline 45.6% of children and 61% of adults with a positive SPT also had a doctor’s diagnosis of allergy.

Patterns of SPT Positivity at Baseline

The most prevalent allergens were grass mix and mites mix (20.8% and 22.1%, respectively, in children/adolescents; 20.7% and 19.2% in adults, Figure 2). The prevalence of sensitization was significantly higher in adulthood than childhood/adolescence for mugwort, ash tree, early tree mix, dog dander, cat dander and ribwort, while mite mix and mildew positivity were significantly more common in childhood. The prevalence of SPT positivity for every allergen was significantly higher in males than females, with the exception of mugwort and ragweed for childhood/adolescence (Figure 3). In adulthood, the prevalence of every allergen was higher in males than in females (Figure 4)
Figure 2

Prevalence of specific SPT at baseline in childhood /adolescence vs adulthood. *p<0.05 childhood/adolescence vs adulthood.

Figure 3

Prevalence of each allergen in childhood/adolescence by gender. *p<0.05 male vs female.

Figure 4

Prevalence of each allergen in adulthood by gender. *p<0.05 male vs female.

Prevalence of specific SPT at baseline in childhood /adolescence vs adulthood. *p<0.05 childhood/adolescence vs adulthood. Prevalence of each allergen in childhood/adolescence by gender. *p<0.05 male vs female. Prevalence of each allergen in adulthood by gender. *p<0.05 male vs female.

Determining Factors of Sensitization in Childhood/Adolescence and Adulthood at Baseline

In univariate analyses, in both age groups a positive SPT was more likely in males, and those with high income status, doctor´s diagnosis of allergy or asthma, parental allergy, and symptoms of wheezing and rhinitis (). In the multivariate regression analyses in children/adolescents, males were 1.68 times (68%) more likely to have a positive SPT than females (p<0.001) (Table 2). Adjusted for sex, other factors associated with an increased likelihood of a positive SPT were age category 10–<15 or 15-<19 years vs 6–<10 years (ORs 1.94 and 2.30, p<0.001; respectively), and higher eosinophil count (OR 9.87; p<0.001). A dog in the household was associated with a decreased likelihood of a positive SPT (ORs 0.65, p=0.024; respectively).
Table 2

Associated Factors for a Positive SPT in Childhood/Adolescence at Baseline, Mutually Adjusted (N=1439)

FactorsORp-value[95% CI]
Positive association
Sex, male vs female1.68<0.001[1.28–2.19]
Age group, years (ref: 6–<10 years)
 10–<151.940.008[1.38–2.73]
 15–<192.300.030[1.61–2.30]
Eosinophil, 109/L (continuous absolute value)9.87<0.001[4.81–20.24]
Negative association
Dog in household, current, yes vs no0.650.024[0.45–0.94]
Cat in household, current, yes vs no0.710.010[0.50–1.00]

Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference group; SPT, skin prick test.

Associated Factors for a Positive SPT in Childhood/Adolescence at Baseline, Mutually Adjusted (N=1439) Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference group; SPT, skin prick test. In the multivariate regression analyses in adults, males were 1.86 times (86%) more likely to have a positive SPT than females (p<0.001) (Table 3). Adjusted for sex, other factors associated with an increased likelihood of a positive SPT were high SES (OR 1.27, p<0.001), parental allergy (OR 1.26, p<0.001), and higher eosinophil count (OR 3.54; p<0.001). Former (OR 0.83; p=0.002), current (OR 0.76; p<0.001), and second-hand smoking (OR 0.87; p=0.008) were associated with a decreased likelihood of a positive SPT.
Table 3

Associated Factors for a Positive SPT in Adulthood at Baseline, Mutually Adjusted (N=9844)

FactorsORp-value[95% CI]
Positive association
Sex, male vs female1.86<0.001[1.77–2.16]
Age group, years (ref: 19–<30 years)
 30–<400.760.001[0.64–0.90]
 40–<500.73<0.001[0.62–0.86]
 50–<600.54<0.001[0.46–0.64]
 60–<700.47<0.001[0.39–0.56]
 ≥700.38<0.001[0.31–0.46]
SES categories (ref: normal)
High SES1.27<0.001[1.14–1.41]
Parental allergy (doctor’s diagnosis), yes vs no1.26<0.001[1.10–1.48]
Eosinophil, 109/L (continues absolute value)3.54<0.001[2.44–5.12]
Negative association
Smoking status (ref: never smoker)
 Former smoking0.830.002[0.74–0.94]
 Current smoking0.76<0.001[0.67–0.87]
 Second-hand smoking0.870.018[0.79–0.97]

Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference group; SES, socio-economic status; SPT, skin prick test.

Associated Factors for a Positive SPT in Adulthood at Baseline, Mutually Adjusted (N=9844) Abbreviations: CI, confidence interval; OR, odds ratio; ref, reference group; SES, socio-economic status; SPT, skin prick test.

Follow-Up Data of SPT Positivity

The overall prevalence of sensitization at the 4-year follow-up visit was 38.6%. In childhood/adolescence, 94.0% (N=268) of the participants with a positive SPT at baseline remained positive at follow-up; 15.6% (N=77) of those who tested negative at baseline tested positive at follow-up. 6% (N=17) of initially positive tested children lost their SPT positivity. Of the 2468 adults with a positive baseline SPT, 87.7% (N=2164) were also positive at follow-up, with 8.8% (N= 370) newly testing positive at 4 years. In adulthood 12.3% (N=304) were tested positive at baseline and then negative after 4-year follow-up. Between baseline and the 4-year follow-up, there was an overall increase in the number of positive SPT reactions, especially in childhood/adolescence, with more than half of those who had one positive SPT at baseline having an increase in the number of positive SPTs at follow-up in both age categories (Figures 5 and 6).
Figure 5

Flow graph of positive skin prick test at baseline and after a 4-year follow-up period in childhood/adolescence.

Figure 6

Flow graph of positive skin prick test at baseline and after a 4-year follow-up period in adulthood.

Flow graph of positive skin prick test at baseline and after a 4-year follow-up period in childhood/adolescence. Flow graph of positive skin prick test at baseline and after a 4-year follow-up period in adulthood.

Discussion

In this population-based study, we found that: (1) a positive SPT to aero-allergens is common throughout the population; (2) a positive SPT is more likely in males than in females, except for those aged 10–<15 years; (3) the most prevalent reactions are to grass and mite mixes; (4) there are some differences in factors associated with a positive SPT between children/adolescents and adults; (5) there is an attenuation of SPT positivity with older age; (6) and finally there is an increase in positive SPT reactions over the 4-year follow up period, especially in childhood/adolescence. The overall prevalence of sensitization at baseline to at least one of the allergens tested was 37.6%. Prior reported prevalence rates vary, ranging from 17–69%.10,26 Our results are broadly consistent with those of the Global Allergy and Asthma European Network (GA2LEN), in which the prevalence in participants from Vienna of positive reactions to the allergens tested was higher than in other countries; for example, 46% of the Viennese participants had a sensitization to grass pollen, compared to 26% from the Netherlands and 33% from Germany.27 In our study, peak sensitization occurred at the ages of 10–<15 years in females and 19–<29 years in males. These data are consistent with the National Health and Nutrition Examination Survey, in which peak prevalence was at the age of 12–24 years,5 and with prevalence data from children in Belgium, which peaked at the ages of 10–12 years.6 Increased rates of birth by cesarean delivery, increased use of antibiotics, westernized diet and association with obesity, changes in indoor and outdoor life style and activity patterns owing to modernization are considered to have an important role.28,29 The increase in prevalence and intensity of SPT positivity over the follow-up period is especially interesting. Positive SPT reactions increase by 94 children/adolescents and 66 adults, with overall increase observed in the number of positive SPTs. Although ideally these data should be confirmed by specific immunoglobulin E (IgE) measurements, they potentially indicate the impact of continuous exposure to environmental triggers. The level of serum IgE appears to be associated with the severity of symptoms in participants with allergic rhinitis.30 In a longitudinal study in children studied from birth to 20 years of age, none with a positive SPT at the age of 5 years had a subsequent negative SPT, whereas 23% of those with a negative SPT at the age of 5 years had a positive SPT at 11 years and 19% with a negative SPT at the age of 11 years had a positive SPT at 20 years.20 One explanation for the increase over time not only in allergy but in auto-immunity and other chronic conditions is the epithelial barrier hypothesis.29 The regular follow-up of SPT could potentially be an inexpensive, non-invasive marker of epithelial barrier dysfunction, and to monitor other affected tissues.29 To summarize in our study: we observed an increase of prevalence of sensitization over the 4-year follow-up period and an increase of polysensitization after 4 years in both age groups but especially in children/adolescents. There was a male predominance of SPT positivity over almost the whole studied age range, except from 10–<15 years. Male sex as a risk factor for sensitization is well described and recognized in the literature,31 but the underlying mechanisms are poorly understood. Sex distributions could be related to an increase in female hormones, especially estrogen, which is known to play an important role in the mechanism of sensitization.32,33 Previous studies reported higher IgE values and eosinophil counts in males than females.34,35 Future research is needed to explore this sex difference and the possible role of hormone homeostasis on Type I sensitization.31,32,36 There is less information on the prevalence of atopy in the older population. The prevalence of any positive SPT at baseline was 55.3% in those aged of 20–29 years and 35.6% in those aged 40–49 years; after a 10-year follow-up period, these values decreased to 40.0% and 23.7%, respectively.10 In both childhood/adolescence and adulthood, house dust mite (22.1% and 19.2%) and grass mix (20.8% and 20.7%) were the most prevalent allergens, confirming previous data.37 The presence of a dog in household showed a negative association with a positive skin prick test in children and adolescents. The role of domiciliary dog and cat exposure at home in terms of sensitization remains controversial. Some studies have reported a decreased risk of sensitization in those who lived with a cat or a dog during their first 5 years of life,4 whereas others did not find any effect of cats or dogs on sensitization levels.16,38 Considering the concept of inflammatory resilience, living conditions linked to environmental micro-organisms early in life seem very important.15,28 Neither smoking habits nor exposure to tobacco smoke were associated with SPT sensitization in children/adolescents, although they were associated with a 10–20% decreased likelihood of a positive SPT in adults. Similarly, there were negative effects of former and current smoking on the likelihood of sensitization only in adults. We tried to avoid confounding factors by differentiating between maternal and parental smoking, and by asking specifically about second-hand smoking. However, the role of smoking and sensitization remains controversial. Paternal smoking during childhood is associated with an increased risk of sensitization in offspring, while maternal smoking is associated with a (non-significant) decreased risk.39,40 Sustained smoking itself is reported to reduce the likelihood of sensitization.11,41 Cross-sectional studies have shown a negative association of current smoking and sensitization,42,43 while others report an increasing risk of sensitization to aero- and/or food allergens,44–46 while yet others did not find any association.47 Blood eosinophil correlated with the likelihood of a positive SPT, especially in childhood/adolescence. A recent study showed a clear association between specific IgE sensitization and an increase eosinophil concentration in an adult Danish population.48 However, more studies are needed to understand the exact mechanism on the impact of blood eosinophilia and SPT positivity. We found a 27% higher likelihood of a positive SPT in adults with higher SES, but not in children/adolescents. Previous studies reported that the higher the educational status the higher was the likelihood of sensitization.39,49,50 Future studies need to explore whether SES is an indicator of differences in domestic living conditions or exposure to other environmental triggers, particularly in adulthood. A strength of our study is the population-based recruitment of the participants, representative of the general Austrian population in terms of age, sex, and smoking status over ages ranging from 6 to 82 years. Other strengths are that all tests were conducted in a single center by trained technicians following standardized operating procedures. One of the limitations is that we tested only for aero-allergens. In addition, no information is available about participants’ housing conditions, domestic living conditions, or exposure to other triggers such as detergents used in laundry,51 dishwashing or other household cleaning agents.29 Due to the high number of measurements and examination within this population based study we had to do the average diameter method, however the scanned area method is theoretically more accurate in determining the SPT wheal area.52 Finally, no information is available on early life sensitization risk factors, such as cesarean delivery, antibiotic use during pregnancy, or early in life, or duration of breastfeeding. In conclusion, this study confirms that sensitization is highly prevalent in all age groups in this Austrian population cohort, peaking in adolescence but persisting during adulthood, and with determining factors of sensitization differing between childhood/adolescence and adulthood. Importantly, we observed an increase in both the prevalence of sensitization and in the number of positive reactions over the 4-year follow-up period. Longitudinal monitoring of sensitization in children/adolescents particularly will become important to identify environmental triggers related to changes in urbanization, industrialization and lifestyle and contributing to increased allergy related burden of disease.
  51 in total

1.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

2.  Blood eosinophil count in the general population: typical values and potential confounders.

Authors:  Sylvia Hartl; Marie-Kathrin Breyer; Otto C Burghuber; Alina Ofenheimer; Andrea Schrott; Matthias H Urban; Alvar Agusti; Michael Studnicka; Emiel F M Wouters; Robab Breyer-Kohansal
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

Review 3.  Risk factors for asthma and atopy.

Authors:  L Karla Arruda; Dirceu Solé; Carlos E Baena-Cagnani; Charles K Naspitz
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-04

4.  Precision allergy: Separate allergies to male and female dogs.

Authors:  Ann-Marie Malby Schoos; Klaus Bønnelykke; Bo Lund Chawes; Jakob Stokholm; Hans Bisgaard; Bjarne Kristensen
Journal:  J Allergy Clin Immunol Pract       Date:  2017-05-09

5.  Allergen skin prick testing in early childhood: reproducibility and prediction of allergic symptoms into early adulthood.

Authors:  Maria Pesonen; Markku J T Kallio; Martti A Siimes; Annamari Ranki
Journal:  J Pediatr       Date:  2014-11-12       Impact factor: 4.406

6.  The association of allergic symptoms with sensitization to inhalant allergens in childhood.

Authors:  Elke Govaere; Dirk Van Gysel; Katia M C Verhamme; Erenik Doli; Frans De Baets
Journal:  Pediatr Allergy Immunol       Date:  2008-10-06       Impact factor: 6.377

7.  The influence of age and gender on sensitization to aero-allergens.

Authors:  Elke Govaere; Dirk Van Gysel; Guy Massa; Katia M C Verhamme; Erenik Doli; Frans De Baets
Journal:  Pediatr Allergy Immunol       Date:  2007-12       Impact factor: 6.377

8.  Lung function at age 3 years: effect of pet ownership and exposure to indoor allergens.

Authors:  Lesley A Lowe; Ashley Woodcock; Clare S Murray; Julie Morris; Angela Simpson; Adnan Custovic
Journal:  Arch Pediatr Adolesc Med       Date:  2004-10

9.  Exposure to environmental tobacco smoke and sensitisation in children.

Authors:  E Lannerö; M Wickman; M van Hage; A Bergström; G Pershagen; L Nordvall
Journal:  Thorax       Date:  2007-12-18       Impact factor: 9.139

10.  Combinations of self-reported rhinitis, conjunctivitis, and asthma predicts IgE sensitization in more than 25,000 Danes.

Authors:  Susan Mikkelsen; Khoa Manh Dinh; Jens Kjaergaard Boldsen; Ole Birger Pedersen; Gitte Juel Holst; Mikkel Steen Petersen; Kathrine Agergård Kaspersen; Bjarne Kuno Møller; Kaspar Rene Nielsen; Helene Martina Paarup; Klaus Rostgaard; Henrik Hjalgrim; Erik Sørensen; Linda Jenny Handgaard; Thomas Folkmann Hansen; Karina Banasik; Kristoffer Sølvsten Burgdorf; Henrik Ullum; Torben Sigsgaard; Christian Erikstrup
Journal:  Clin Transl Allergy       Date:  2021-03       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.